← All stocks

Spyre Therapeutics, Inc.

SYRE Scheduled selling only

CIK 0001636282 #969 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$6.07M

$2.94M on a plan · $3.14M straight out of an exercise

Sold at will

$0.00

0 of 14 sales

Net

−$6.07M

$0.00 against sales at will

By person

7 insiders · 14 transactions

74.2×

Cameron Turtle holds 74.2 times base salary in stock. $49.37M of shares against $665.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Cameron Turtle last reported holding, valued at $89.35, the price Common Stock was last bought or sold at on the open market here, on 2 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

King-Jones Heidy

See Remarks

—

$2.48M (5) scheduled

−$2.48M

2,845

0.0032%

$254.20K

0.0%

Burrows Scott L

Chief Financial Officer

—

$2.28M (5) scheduled

−$2.28M

79,762

0.0905%

$7.13M

−31.5%

Turtle Cameron

Chief Executive Officer

—

$1.31M (4) scheduled

−$1.31M

552,540

0.6266%

$49.37M

−26.1%

HENDERSON MICHAEL THOMAS

Director

—

68,606

0.0778%

$6.13M

—

Albers Jeffrey W.

Director

—

9,360

0.0106%

$836.32K

−72.8%

Fairmount Funds Management LLC entity

Director

—

0.0000%

$0.00

−100.0%

Sloan Sheldon

Chief Medical Officer

—

0.0000%

$0.00

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Burrows Scott L

2 Sep 2026

Chief Financial Officer

Sold on a plan

18,232

$89.35

$1.63M

Turtle Cameron

1 Sep 2026

Chief Executive Officer

Sold on a plan

400

$89.07

$35.63K

Turtle Cameron

1 Sep 2026

Chief Executive Officer

Sold on a plan

3,700

$88.06

$325.82K

Turtle Cameron

1 Sep 2026

Chief Executive Officer

Sold on a plan

8,400

$87.15

$732.06K

Turtle Cameron

1 Sep 2026

Chief Executive Officer

Sold on a plan

2,500

$86.36

$215.90K

Show all 14 transactions →

What was left out

Form 4 filings counted 3

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 5

Sales straight out of an exercise 9

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 35,899

History held since 16 Feb 2017